从2型糖尿病自我护理支持干预试验中提前随机撤回与缺乏可用支持人员的缺乏相关
McKenzie K Roddy1,2,3, Merna El-Rifai3, Lauren LeStourgeon3
1VA Quality Scholars Program, VA Tennessee Valley Healthcare System, Nashville, TN, USA.
Chronic illness
|September 26, 2023
概括
在慢性疾病干预中激活支持人员 (SP) 可以帮助招聘. 在2型糖尿病试验中,自愿的SP联合注册显示出高参与率,但在没有SP的人群中,早期戒断率增加.
科学领域:
- 临床研究 临床研究
- 健康心理学 心理健康心理学
- 糖尿病管理 糖尿病管理
背景情况:
- 双干预利用支持人员 (SPs) 来改善慢性疾病成年人的健康结果.
- 强制性SP参与可能会阻碍招聘,并引入抽样偏见.
- 自愿的SP共同注册对招聘和患者特征的影响仍然不清楚.
研究的目的:
- 描述随机对照试验 (RCT) 在二次性干预环境中与自愿支持人员 (SP) 共同招募的入学情况.
- 检查自愿SP共参与和招聘结果之间的关联.
- 确定影响SP邀请和入学的患者特征.
主要方法:
- 家庭/朋友激活以激励自我照顾2.0随机对照试验 (RCT) 招募了2型糖尿病 (T2D) 的成年人.
- 鼓励参与者,但不要求邀请SP共同注册.
- 电子健康记录数据被用来分析入学模式和结果.
主要成果:
- 在一个多元化的T2D样本中,91%的受访者邀请了SP,89%的受访者加入了SP.
- 在没有同意的SPs的参与者中,随机化前退出率更高.
- 女人不太可能邀请SP; 患有糖尿病的黑人有更高的预先随机化戒断率.
结论:
- 自愿的SP共同注册可能会增加对二极性研究的招聘.
- 需要进一步的研究来评估潜在的系统采样偏差.
- 减轻二次招募中的意外偏见的策略需要进行调查.
相关概念视频
Randomized Experiments
7.0K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
7.0K
Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Censoring Survival Data
125
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
125


